Cargando…

Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry

Cysteine–cysteine chemokine receptor 5 (CCR5) has been discovered as a co-receptor for cellular entry of human immunodeficiency virus (HIV). Moreover, the role of CCR5 in a variety of cancers and various inflammatory responses was also discovered. Despite the fact that several CCR5 antagonists have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Pooja, Kumar, Vikas, Lee, Gihwan, Jung, Tae Sung, Ha, Min Woo, Hong, Jong Chan, Lee, Keun Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784205/ https://www.ncbi.nlm.nih.gov/pubmed/36555761 http://dx.doi.org/10.3390/ijms232416122

Ejemplares similares

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors
por: Kumar, Vikas, et al.
Publicado: (2022)

Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics
por: Parate, Shraddha, et al.
Publicado: (2021)

Discovery of Non-Peptidic Compounds against Chagas Disease Applying Pharmacophore Guided Molecular Modelling Approaches
por: Rampogu, Shailima, et al.
Publicado: (2018)

Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
por: Parate, Shraddha, et al.
Publicado: (2021)

Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer
por: Danishuddin,, et al.
Publicado: (2021)

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics
por: Rampogu, Shailima, et al.
Publicado: (2021)

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
por: John, Shalini, et al.
Publicado: (2011)

Computational Simulations Highlight the IL2Rα Binding Potential of Polyphenol Stilbenes from Fenugreek
por: Kulkarni, Apoorva M., et al.
Publicado: (2022)

Pharmacophoric Site Identification and Inhibitor Design for Autotaxin
por: Lee, Myeong Hwi, et al.
Publicado: (2019)

Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2
por: Kumar, Vikas, et al.
Publicado: (2021)

Exploring the Binding Interaction of Raf Kinase Inhibitory Protein With the N-Terminal of C-Raf Through Molecular Docking and Molecular Dynamics Simulation
por: Parate, Shraddha, et al.
Publicado: (2021)

Dynamic and Multi-Pharmacophore Modeling for Designing Polo-Box Domain Inhibitors
por: Sakkiah, Sugunadevi, et al.
Publicado: (2014)

3D QSAR Pharmacophore Modeling, in Silico Screening, and Density Functional Theory (DFT) Approaches for Identification of Human Chymase Inhibitors
por: Arooj, Mahreen, et al.
Publicado: (2011)

Discovery of Lonafarnib-Like Compounds: Pharmacophore Modeling and Molecular Dynamics Studies
por: Rampogu, Shailima, et al.
Publicado: (2020)

Determination of Adequate Entry Angle of Lumbar Sympathetic Ganglion Block in Korean
por: Kim, Won Ho, et al.
Publicado: (2010)

Natural Compound Modulates the Cervical Cancer Microenvironment—A Pharmacophore Guided Molecular Modelling Approaches
por: Rampogu, Shailima, et al.
Publicado: (2018)

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
por: John, Shalini, et al.
Publicado: (2011)

Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods
por: Kulkarni, Apoorva M., et al.
Publicado: (2022)

A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors
por: Arooj, Mahreen, et al.
Publicado: (2013)

Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design
por: Thangapandian, Sundarapandian, et al.
Publicado: (2012)

Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2
por: Rampogu, Shailima, et al.
Publicado: (2022)

Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery
por: Thangapandian, Sundarapandian, et al.
Publicado: (2011)

Binding Mode Analyses and Pharmacophore Model Development for Stilbene Derivatives as a Novel and Competitive Class of α-Glucosidase Inhibitors
por: Lee, Yuno, et al.
Publicado: (2014)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

Biochemical and Structural Insights Concerning Triclosan Resistance in a Novel YX(7)K Type Enoyl-Acyl Carrier Protein Reductase from Soil Metagenome
por: Khan, Raees, et al.
Publicado: (2019)

Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations
por: Son, Minky, et al.
Publicado: (2013)

Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
por: Mirza, Muhammad Usman, et al.
Publicado: (2021)

Computational Exploration for Lead Compounds That Can Reverse the Nuclear Morphology in Progeria
por: Rampogu, Shailima, et al.
Publicado: (2017)

Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape
por: Rampogu, Shailima, et al.
Publicado: (2021)

Nasal symbiont Staphylococcus epidermidis restricts the cellular entry of influenza virus into the nasal epithelium
por: Jo, Ara, et al.
Publicado: (2022)

Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
por: Berro, Reem, et al.
Publicado: (2009)

CCR4 and CCR5 Involvement in Monocyte-Derived Macrophage Migration in Neuroinflammation
por: Kim, Jong Youl, et al.
Publicado: (2022)

Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations
por: Kumar, Vikas, et al.
Publicado: (2021)

Essential oils block cellular entry of SARS-CoV-2 delta variant
por: Torres Neto, Luiz, et al.
Publicado: (2022)

The Effect of MCP-1/CCR2 on the Proliferation and Senescence of Epidermal Constituent Cells in Solar Lentigo
por: Lee, Woo Jin, et al.
Publicado: (2016)

Development of a Short Form Depression Screening Questionnaire for Korean Soldiers
por: Byeon, Gihwan, et al.
Publicado: (2021)

Lead identification and optimization of novel collagenase inhibitors; pharmacophore and structure based studies
por: Kalva, Sukesh, et al.
Publicado: (2012)

Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands
por: Parate, Shraddha, et al.
Publicado: (2021)

Investigating natural compounds against oncogenic RET tyrosine kinase using pharmacoinformatic approaches for cancer therapeutics
por: Parate, Shraddha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pqda5vujh5nt3clug3404k6ce2